Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 15 to 23 amino acid residues in defined sequence
Patent
1993-09-17
1997-10-07
Hendricks, Keith D.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
15 to 23 amino acid residues in defined sequence
530377, 530328, 530329, 530330, 435232, C07K 14435, C07K 700, C12N 988
Patent
active
056749783
ABSTRACT:
Isolated polypeptides useful in ameliorating GAD-associated autoimmune disease as well as diagnostic and therapeutic methods of using the peptides are disclosed.
REFERENCES:
patent: 4487830 (1984-12-01), Coates et al.
patent: 4624926 (1986-11-01), Inouye et al.
patent: 4751181 (1988-06-01), Keene
patent: 5200318 (1993-04-01), Rabin et al.
Geysen et al., PNAS, vol. 81, pp. 3998-4002, 1984.
Bu et al., PNAS, vol. 89, pp. 2115-2119, Mar. 1992.
Revelation of Specificity of 64K Autoantibodies in IDDM Serums by High-Resolution 2-D Gel Electrophoresis Baekkeskov, et al., Diabetes, 38:1133-1141, 1989.
Antigen Recognition in Autoimmune Encephalomyelitis and the Potential for Peptide-Mediated Immunotherapy Wraith, et al., Cell, 59:247-255, Oct. 20, 1989.
Effect of Coxsackievirus B4 Infection in Mice on Expression of 64,000-M Autoantigen and Glucose Sensitivity of Islets Before Development of . . . Gerling, et al., Diabetes, 37:1419-1425, 1988.
Molecular Mimicry and Diabetes Dyrberg, Current Topics in Microbiology & Immun., 145:118-125, 1989.
Rat Brain Glutamic Acid Decarboxylase Sequence Deduced from a Cloned cDNA Julien, et al., Journal of Neurochemistry, 54:703-705, 1990.
Molecular Mimicry and Myasthenia Gravis Schwimmbeck, et al., J. Clin. Invest., 84:1174-1180, Oct. 1989.
A molecular basis for genetic susceptibility to insulin-dependent diabetes mellitus Todd, et al., TIG, No.5, 4:129-134, May 1988.
Characterization of the Proteins Purified with Monoclonal Antibodies to Glutamic Acid Decarboxylase Chang and Gottlieb, The Journal of Neuroscience, No.8, 6:2123-2130, Jun. 1988.
Evidence for Two Distinct forms of Native Glutamic Acid Decarboxylase in Rat Brain Soluble Extract: An Immunoblotting Study Legay, et al., Journal of Neurochemistry, 48:1022-1026, 1987.
Molecular cloning, expression and in situ hybridization of rat brain glutamic acid decarboxylase messenger RNA Julien, et al., Neuroscience Letters, 73:173-180, 1987.
Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase Baekkeskov, et al., Nature, 347:151-156, Sep. 13, 1990.
Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus Michelesen, et al., Proc. Natl. Acad. Sci. USA, 88:8754-8758, Oct. 1991.
Autoantibodies to GABA-.sup.ergic Neurons and Pancreatic Beta Cells in Stiff-Man Syndrome Solimena, et al., N. Engl. J. Med., 322:1555-1560, 1990.
Glutamic Acid Decarboxylase cDNA: Nucleotide Sequence Encoding and Enzymatically Active Fusion Protein Kobayashi, et al., The Journal of Neuroscience, No. 7, 9:2768-2772, Sep. 1987.
What Causes Diabetes? Atkinson & Maclaren, Scientific American, pp. 62-71, Jul. 1990.
Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins Baekkeskov, et al., Nature, 298:167-169, Jul. 1982.
Antibodies to a 64,000 M.tau. Human Inslet Cell Antigen Precede the Clinical Onset of Insulin-dependent Diabetes Baekkeskov, et al., J. Clin. Invest., 79:926-934, Mar. 1987.
Cellular and Subcellular Localization of an M.tau. 64,000 Protein Autoantigen in Insulin-dependent Diabetes Christie, et al., The Journal of Biological chemistry, No.1, 265:376-381, Jan. 5, 1990.
64,000 M.tau. autoantibodies as predictors of insulin-dependent diabetes Atkinson, et al., The Lancet, 335:1357-1360, 1990.
Predicting Type I Diabetes Ziegler, et al., Diabetes Care, 13:762-775, 1990.
Brain Glutamate Decarboxylase Cloned in .lambda.gt-11: Fusion Protein Produces .tau.-Aminobutyric Acid Kaufman, et al., Science, 232:1138-1140, May 30, 1986.
Characterization of a cDNA coding for rat glutamic acid decarboxylase Wyborski, et al., Molecular Brain Research, 8:193-198, 1990.
Molecular Identification of the 62 kd Form of Glutamic Acid Decarboxykase from the Mouse Katarova, et al., European Journal of Neuroscience, No.3, 2:190-202, 1990.
Expression of the Neurotransmitter-Synthesizing Enzyme Glutamic Acid Decarboxylase in Male Germ Cells Persson, et al., Molecular and Cellular Biology, No.9, 10:4701-4711, Sep. 1990.
Autoimmunity to Two Forms of Glutamate Decarboxylase in Insulin-dependent Diabetes Mellitus Kaufman, et al., J. Clin. Invest., 89:283-292, Jan. 1992.
Determinant spreading and the dynamics of the autoimmune T-cell repertoire Lehmann, et al., Immunology Today, No.5, 14:203-208, 1993.
Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes Atkinson, et al., The Lancet, 339:458-459, Feb. 22, 1992.
Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes Harrison, et al., The Lancet, 341:1365-1369, May 29, 1993.
Autoantibodies to Glutamic Acid Decarboxylase in a Patient with Stiff-Man Syndrome, Epilepsy, and Type I Diabetes Mellitus Solimena, et al., N. Engl. J. Med., 318:1012-1020, Apr. 21, 1988.
Clare-Salzler Michael J.
Erlander Mark G.
Kaufman Daniel L.
Tobin Allan J.
Hendricks Keith D.
The Regents of the University of California
LandOfFree
Peptides derived from glutamic acid decarboxylase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides derived from glutamic acid decarboxylase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides derived from glutamic acid decarboxylase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2358250